scispace - formally typeset
W

Wenqing Li

Researcher at Ohio State University

Publications -  21
Citations -  727

Wenqing Li is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Trans-activating crRNA. The author has an hindex of 10, co-authored 18 publications receiving 313 citations.

Papers
More filters
Journal ArticleDOI

Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis

TL;DR: It is shown that adoptive transfer of macrophages containing antimicrobial peptides linked to cathepsin B in the lysosomes can be applied for the treatment of multidrug-resistant bacteria-induced sepsis in mice with immunosuppression.
Journal ArticleDOI

Long-term storage of lipid-like nanoparticles for mRNA delivery

TL;DR: This study investigated a series of conditions for the long-term storage of LLNs with encapsulation of mRNA, and found that the addition with 5% sucrose or trehalose to LLNs could remain their mRNA delivery efficiency for at least three months in the liquid nitrogen storage condition.
Journal ArticleDOI

Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice

TL;DR: A ratiometric fluorescent probe effectively captured endogenous HClO in the lungs of a lipopolysaccharide (LPS)-induced lung inflammation mouse model after intravenous administration.
Journal ArticleDOI

Recent advances of antibody drug conjugates for clinical applications.

TL;DR: This review summarizes the key elements of ADCs and highlights recent advances ofADCs, as well as important lessons learned from clinical data, and future directions.
Journal ArticleDOI

Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing

TL;DR: A series of lipid-like nanomaterials (LLNs), named functionalized TT derivatives (FTT), are constructed for mRNA-based therapeutic applications in vivo, and FTT5 LLNs demonstrated high percentage of base editing on PCSK9 in vivo at a low dose of base editor mRNA and single guide RNA.